The call comes after latest research found that QRISK gives a more accurate prediction of cardiovascular disease (CVD) than Framingham.
Previous studies have shown that QRISK is more accurate, but NICE continues to recommend Framingham.
The guidance for the vascular checks programme states that either QRISK or Framingham can be used to calculate risk.
This latest study found that for every performance measure, QRISK gave a more accurate prediction of 10-year cardiovascular disease risk compared with Framingham.
The rate of CVD events among men was 30.5 per 1,000 person years in high-risk patients identified with QRISK and 23.7 per 1,000 person years in high-risk patients identified with Framingham.
The researchers, Dr Gary Collins and Professor Douglas Altman, concluded that QRISK performs better than the Framingham risk score in terms of identifying a high-risk population for CVD in the UK.
More news from 8 July
Northern Ireland refuses to fund swine flu work
Swine flu: contract suspension set for hotspots only
Exclusive: Dramatic fall in doctors applying for general practice
Practices bid for GP funds to expand training
NMC still has substantial room for improvement